DAEWOONG PHARMA financial statements, including revenue, expenses, profit, and loss

The total revenue of 069620 for the last quarter is 361.82 B KRW, and it's 6.14% higher compared to the previous quarter. The net income of Q4 23 is 66.01 B KRW.